Rethinking Referral Pathways: Qualitative Evaluation of General Practice Networks to Increase Access to Intrauterine Contraception

Overview

Journal Fam Pract

Publisher Oxford University Press

Specialty Public Health

Date 2022 Apr 29

PMID 35485435

Authors

Sara F E Bell

Caroline Harvey

Fiona Mack

Stephen Lambert

Mattea Lazarou

Kay Strom

Judith A Dean

Affiliations

Soon will be listed here.

Abstract

Background: Long-acting reversible contraceptives are recommended first-line contraception; however, intrauterine device (IUD) uptake remains low in Australia.

Objectives: To describe the outcomes of an independent evaluation of the General Practitioner IUD Insertion Network (GPIIN), a project designed to address access barriers through formalized referral pathways between general practitioners (GPs) inserting IUDs and noninserters.

Methods: An independent qualitative pragmatic inductive evaluation, involving 14 in-depth interviews with GPIIN members, was conducted 18 months post-GPIIN implementation in 2 Australian jurisdictions to identify and explore critical success factors and limitations of the model.

Results: Local GP-to-GP IUD referral networks were considered a useful model to assist affordable and timely IUD access, improve noninserters' IUD knowledge and inserters' reflection on best practice. However, pathway simplification is needed to determine optimal integration of the concept into pragmatic GP-to-GP referral arrangements.

Conclusions: GPIIN provides an opportunity to improve IUD access in Primary Health Care. Further consideration of organizations best positioned and resourced to facilitate sustainable delivery and coordination is necessary.

References

Mazza D, Harrison C, Taft A, Brijnath B, Britt H, Hobbs M . Current contraceptive management in Australian general practice: an analysis of BEACH data. Med J Aust. 2012; 197(2):110-4. DOI: 10.5694/mja11.11599. View

Goldstuck N, Cheung T . The efficacy of intrauterine devices for emergency contraception and beyond: a systematic review update. Int J Womens Health. 2019; 11:471-479. PMC: 6709799. DOI: 10.2147/IJWH.S213815. View

Kolman K, Hadley S, Jordahl-Iafrato M . Long-acting reversible contraception: who, what, when, and how. J Fam Pract. 2015; 64(8):479-84. View

Black K, Hussainy S . Emergency contraception: Oral and intrauterine options. Aust Fam Physician. 2017; 46(10):722-726. View

Cruess R, Cruess S, Steinert Y . Medicine as a Community of Practice: Implications for Medical Education. Acad Med. 2017; 93(2):185-191. DOI: 10.1097/ACM.0000000000001826. View

Stewart M, Digiusto E, Bateson D, South R, Black K . Outcomes of intrauterine device insertion training for doctors working in primary care. Aust Fam Physician. 2016; 45(11):837-841. View

Ranmuthugala G, Plumb J, Cunningham F, Georgiou A, Westbrook J, Braithwaite J . How and why are communities of practice established in the healthcare sector? A systematic review of the literature. BMC Health Serv Res. 2011; 11:273. PMC: 3219728. DOI: 10.1186/1472-6963-11-273. View

Booth M, Hill G, Moore M, Dalla D, Moore M, Messenger A . The new Australian Primary Health Networks: how will they integrate public health and primary care?. Public Health Res Pract. 2016; 26(1):e2611603. DOI: 10.17061/phrp2611603. View

Tayabas L, Leon T, Espino J . Qualitative evaluation: a critical and interpretative complementary approach to improve health programs and services. Int J Qual Stud Health Well-being. 2014; 9:24417. PMC: 4142224. DOI: 10.3402/qhw.v9.24417. View

10.

Nguyen J, Williams H, McNamee K, Shafeeu N, Vaisey A, Hocking J . Condom use among young women in Australia using long-acting reversible contraceptives or other hormonal contraceptives. Sex Health. 2019; 16(6):574-579. DOI: 10.1071/SH19045. View

11.

Bingham A, Garrett C, Bayly C, Kavanagh A, Keogh L, Bentley R . The levonorgestrel intrauterine device in Australia: analysis of prescribing data 2008-2012. BMC Womens Health. 2018; 18(1):194. PMC: 6257965. DOI: 10.1186/s12905-018-0680-3. View

12.

Temple-Smith M, Sanci L . LARCs as first-line contraception - What can general practitioners advise young women?. Aust Fam Physician. 2017; 46(10):710-715. View

13.

Lodge G, Sanci L, Temple-Smith M . GPs perspectives on prescribing intrauterine contraceptive devices. Aust Fam Physician. 2017; 46(5):328-333. View

14.

Hopkins B . Barriers to Health Care Providers' Provision of Long-Acting Reversible Contraception to Adolescent and Nulliparous Young Women. Nurs Womens Health. 2017; 21(2):122-128. DOI: 10.1016/j.nwh.2017.02.007. View

15.

McGeoch G, McGeoch P, Shand B . Is HealthPathways effective? An online survey of hospital clinicians, general practitioners and practice nurses. N Z Med J. 2015; 128(1408):36-46. View

16.

Claringbold L, Sanci L, Temple-Smith M . Factors influencing young women's contraceptive choices. Aust J Gen Pract. 2019; 48(6):389-394. DOI: 10.31128/AJGP-09-18-4710. View

17.

Mazza D, Watson C, Taft A, Lucke J, McGeechan K, Haas M . Increasing long-acting reversible contraceptives: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomized trial. Am J Obstet Gynecol. 2019; 222(4S):S921.e1-S921.e13. DOI: 10.1016/j.ajog.2019.11.1267. View

18.

Kumar N, Brown J . Access Barriers to Long-Acting Reversible Contraceptives for Adolescents. J Adolesc Health. 2016; 59(3):248-253. DOI: 10.1016/j.jadohealth.2016.03.039. View

19.

Concepcion K, Lacey S, McGeechan K, Estoesta J, Bateson D, Botfield J . Cost-benefit analysis of enhancing the uptake of long-acting reversible contraception in Australia. Aust Health Rev. 2019; 44(3):385-391. DOI: 10.1071/AH18190. View

20.

Turner R, Tapley A, Sweeney S, Davey A, Holliday E, van Driel M . Prevalence and associations of prescribing of long-acting reversible contraception by general practitioner registrars: a secondary analysis of ReCEnT data. BMJ Sex Reprod Health. 2020; 46(3):218-225. DOI: 10.1136/bmjsrh-2019-200309. View